tibolone has been researched along with c-peptide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dericks-Tan, JS; Helmond, FA; Kuhl, H; Leifels-Fischer, B; Starflinger, F; Tetzloff, W; Wiegratz, I | 1 |
| Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD | 1 |
| Gram, J; Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO | 1 |
| Godsland, IF; Manassiev, N; Proudler, AJ; Stevenson, JC; Whitehead, MI | 1 |
3 trial(s) available for tibolone and c-peptide
| Article | Year |
|---|---|
Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women.
Topics: Blood Glucose; C-Peptide; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Glucose Tolerance Test; Hormone Replacement Therapy; Humans; Insulin; Medrogestone; Middle Aged; Netherlands; Norpregnenes; Postmenopause | 2002 |
The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
Topics: Blood Pressure; Body Composition; C-Peptide; Cardiovascular Diseases; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Norpregnenes; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides | 2008 |
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
Topics: Aged; Blood Glucose; C-Peptide; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Humans; Insulin; Insulin Resistance; Middle Aged; Norethindrone; Norpregnenes | 2013 |
1 other study(ies) available for tibolone and c-peptide
| Article | Year |
|---|---|
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause | 2003 |